Detalhe da pesquisa
1.
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
Br J Cancer
; 101(12): 2048-54, 2009 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19920816